CADILAHC Intraday Analysis...

CADILAHC Share Price

Open 478.00 Change Price %
High 478.00 1 Day -8.20 -1.70
Low 465.00 1 Week -9.10 -1.89
Close 473.40 1 Month -51.05 -9.73
Volume 953394 1 Year 105.45 28.66
52 Week High 560.00
52 Week Low 328.80
CADILAHC Important Levels
Resistance 2 485.45
Resistance 1 480.49
Pivot 472.13
Support 1 466.32
Support 2 461.35
NSE INDIA Most Active Stocks
INFY 923.25 -9.56%
INFY 923.25 -9.56%
JPASSOCIAT 22.80 -2.98%
GMRINFRA 18.25 -1.62%
SUZLON 16.95 -1.45%
RCOM 24.15 4.09%
UNITECH 7.55 -1.95%
GVKPIL 13.50 1.89%
SINTEX 33.30 -4.03%
MEGH 74.60 14.15%
More..
NSE INDIA Top Gainers Stocks
LCCINFOTEC 0.25 25.00%
PODDARHOUS 1349.15 20.00%
INOXWIND 128.60 19.85%
PITTILAM 64.35 19.28%
COMPINFO 30.75 17.59%
NATHBIOGEN 400.35 14.78%
PRAKASHSTL 0.40 14.29%
MEGH 74.60 14.15%
HUBTOWN 113.85 11.67%
AARVEEDEN 35.50 9.91%
More..
NSE INDIA Top Losers Stocks
SPYL 0.20 -20.00%
INFY 923.25 -9.56%
INFY 923.25 -9.56%
SUNDARAM 2.75 -8.33%
JMTAUTOLTD 4.60 -8.00%
CORALFINAC 64.00 -7.65%
TOKYOPLAST 128.60 -7.32%
ENERGYDEV 17.50 -7.16%
BILENERGY 0.70 -6.67%
GOKUL 23.15 -6.65%
More..

Cadila Healthcare Limited (NSE: CADILAHC)

CADILAHC Technical Analysis 2
As on 18th Aug 2017 CADILAHC Share Price closed @ 473.40 and we RECOMMEND Buy for LONG-TERM with Stoploss of 433.78 & Strong Sell for SHORT-TERM with Stoploss of 520.95 we also expect STOCK to react on Following IMPORTANT LEVELS.
CADILAHC Target for August
1st Target up-side 571.94
2nd Target up-side 591.76
3rd Target up-side 611.59
1st Target down-side 515.36
2nd Target down-side 495.54
3rd Target down-side 475.71
CADILAHC Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 33.12 Sideways
MFI (14) MFI is Below 20 Over Sold
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is -67.51 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 516.38
10 Day Avg Volume Traded -33.88 % Less then 10 Day Average Volume
CADILAHC Other Details
Segment EQ
Market Capital 40527183872.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.zyduscadila.com
CADILAHC Address
CADILAHC
Zydus Tower
Satellite Cross Roads
Ahmedabad, 380015
India
Phone: 91 79 2686 8100
Fax: 91 79 2686 2365
Interactive Technical Analysis Chart Cadila Healthcare Limited ( CADILAHC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cadila Healthcare Limited
CADILAHC Business Profile
Cadila Health is in the Pharmaceuticals sector. Cadila Laboratories was founded in 1952 by Ramanbhai Patel(1952–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Shri Indravadan Modi. The company evolved over the next four decades into one of India's established pharmaceutical companies. In 1995 the Patel and Modi families split, with the Modi family's share being moved into a new company called Cadila Pharmaceuticals Ltd. and Cadila Healthcare became the Patel family's holding company. Cadila Healthcare did its IPO on the Bombay Stock Exchange in 2000. Its stock code on the Bombay exchange is 532321. In 2001 the company acquired another Indian pharmaceutical company called German Remedies. On June 25, 2007, the company signed an agreement to acquire 100 per cent stake in Brazil's Quimica e Farmaceutica Nikkho do Brasil Ltda (Nikkho) for around 26 million dollars. In 2010, Cadila Pharmaceuticals received a prestigious Wellcome Trust Award under the new "R&D for Affordable Healthcare in India" initiative. The current market capitalisation stands at Rs 15,310.07 crore.The company has reported a consolidated sales of Rs 1746.79 crore and a Net Profit of Rs 191.57 crore for the quarter ended Sep 2013. The company management includes Pankaj R Patel - Chairman & Managing Director, Sharvil P Patel - Deputy Managing Director, Humayun Dhanrajgir - Director, Mukesh M Patel - Director, Nitin R Desai - Director, Apurva S Diwanji - Director. It is listed on the BSE with a BSE Code of 532321 and the NSE with an NSE Code of CADILAHC. Its Registered office is at "Zydus Tower", Satellite Cross Roads,,Sarkhej Gandhinagar Highway Ahmedabad,Gujarat - 380015.